Source: International Congress 2014 – The assessment of comorbidities
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. Dag, E. Bulcun, Y. Türkel, A. Ekici, M. Ekici (Kirikkale, Turkey). Factors influencing cognitive function in COPD. Eur Respir J 2014; 44: Suppl. 58, 978

Member's Comments

No comment yet.

Related content which might interest you: Cardiovascular comorbidity in COPD: Tip of iceberg Source: International Congress 2014 – The assessment of comorbidities Year: 2014 Symptoms for anxiety and depression in COPD patients Source: International Congress 2014 – The assessment of comorbidities Year: 2014 Do co-morbidities in patients with chronic obstructive pulmonary disease affect outcomes? Source: International Congress 2014 – The assessment of comorbidities Year: 2014 Assessment of patients preferences regarding characteristics associated with treatment of chronic obstructive pulmonary disease Source: International Congress 2014 – Systemic biomarkers for airway diseases Year: 2014 The importance of dyspnea and airflow limitation for anxiety and depression in COPD Source: International Congress 2014 – Non inflammatory monitoring of airway diseases Year: 2014 Factors influencing compliance to PEF monitoring in asthma Source: Annual Congress 2013 –Asthma treatment and management in children Year: 2013 Frequency of depression in patients with chronic obstructive pulmonary disease Source: International Congress 2014 – The assessment of comorbidities Year: 2014 Influence of psychological characteristics of patients for asthma control Source: International Congress 2014 – The assessment of comorbidities Year: 2014 Pharmacological treatment of COPD in the on-sint cohort Source: International Congress 2014 – COPD exacerbations Year: 2014 Role of comorbidities on mortality in patients hospitalized for COPD exacerbations Source: International Congress 2014 – The assessment of comorbidities Year: 2014 Main and additional predictors of COPD progression Source: International Congress 2014 – Monitoring airway diseases with lung function tests Year: 2014 Effectiveness of a comprehensive management program of fragile COPD patients Source: International Congress 2014 – Phenotyping and monitoring asthma and COPD Year: 2014 Physician attitudes toward questionnaires and indices for COPD.Results of On-Sint study Source: International Congress 2014 – Clinical assessment of airway diseases Year: 2014 Laboratory and clinical parameters in predicting risk of future exacerbations in both non-smoking and smoking COPD patients Source: International Congress 2014 – Systemic biomarkers for airway diseases Year: 2014 Factors associated with uncontrolled asthma in patients with aspirin-exacerbated respiratory disease (AERD) Source: International Congress 2014 – Asthma: still a heterogeneous condition! Year: 2014 Cardiovascular status of patients with a severe form of COPD Source: International Congress 2015 – Diagnosing and management of COPD in primary care Year: 2015 Small airways dysfunction is associated with poorer control in asthmatics with a preserved FEV1 Source: International Congress 2014 – Biomarkers of asthma control Year: 2014 Characteristics of essential hypertension in COPD patients Source: International Congress 2014 – COPD: points to ponder Year: 2014 Associated factors with persistent airflow limitation in asthma in U-BIOPRED Source: Annual Congress 2013 –Studies of asthma in man Year: 2013 Relation of plasma osteopontin levels with the clinical course in patients with COPD Source: International Congress 2014 – Systemic and airway biomarkers Year: 2014